論文 - 詳細
| RRC ID | 69 |
|---|---|
| 著者 | Tanaka K, Towata S, Nakao K, Mizuguchi H, Hayakawa T, Niwa M, Ishii N, Nagayama Y. |
| タイトル | Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model. |
| ジャーナル | Clin Endocrinol (Oxf) |
| Abstract |
BACKGROUND:Introduction of genes encoding immuno-stimulatory cytokine(s) into cancer cells is well known to enhance anti-tumour immunity. AIM:The present studies were designed to evaluate the therapeutic efficacy of retroviral- and adenoviral-mediated delivery of IL-12 and/or granulocyte macrophage colony-stimulating factor (GM-CSF) genes for thyroid cancer in an immuno-competent rat model. METHODS:A rat thyroid cancer cell line FRTL-Tc syngeneic to Fisher rat was used. RESULTS:Expression of these exogenous cytokines did not affect in vitro cell growth. Subcutaneous injection of FRTL-Tc cells retrovirally transduced with IL-12 or GM-CSF genes formed significantly smaller tumours than that of the parental cells, but had little effect on growth of distant tumours, suggesting no vaccine effect. Similarly, injection of the cells infected with adenovirus expressing IL-12 or GM-CSF (AdIL-12 or AdGM-CSF) almost completely abolished tumourigenicity and injection of AdGM-CSF into pre-established tumours significantly inhibited growth of the tumours injected; neither, however, showed a systemic vaccine affect. On the other hand, injection of AdIL-12 into the pre-established tumours significantly inhibited growth of not only the tumours injected but also distant tumours, indicating induction of systemic anti-tumour immunity. Serum IL-12 was detectable only in this approach. There was neither a synergistic or additive effect of these two cytokines. CONCLUSIONS:Our data demonstrate in a rat thyroid cancer model that only injection of AdIL-12 into the pre-established tumours elicited systemic anti-tumour immunity, but injection of AdGM-CSF or injection of the cells expressing IL-12 or GM-CSF elicited only local effect, indicating that in situdelivery of IL-12 gene with adenovirus appears most efficacious but may still require adjuvant modalities to enhance the anti-tumour effect. |
| 巻・号 | 59(6) |
| ページ | 734-42 |
| 公開日 | 2003-12-1 |
| DOI | 10.1046/j.1365-2265.2003.01915.x |
| PII | CEN1915 |
| PMID | 14974915 |
| MeSH | Adenoviridae / genetics Animals Cell Line, Tumor Gene Expression Genetic Engineering Genetic Therapy / methods* Genetic Vectors / administration & dosage Granulocyte-Macrophage Colony-Stimulating Factor / genetics* Granulocyte-Macrophage Colony-Stimulating Factor / immunology Immunotherapy, Active / methods* Injections, Intralesional Interleukin-12 / genetics* Interleukin-12 / immunology Male Models, Animal Neoplasm Transplantation Rats Rats, Inbred F344 Retroviridae / genetics Thyroid Neoplasms / immunology Thyroid Neoplasms / therapy* Transduction, Genetic / methods* |
| IF | 3.38 |
| 引用数 | 5 |
| WOS 分野 | ENDOCRINOLOGY & METABOLISM |
| リソース情報 | |
| 遺伝子材料 | pMFG rat GM-CSF (RDB1463) |
| ラット | |